NEW YORK (GenomeWeb) — University of Pennsylvania spinout Liquid Biotech announced today that it has raised $2 million in seed financing from Japan's Oncolys Biopharma, which it said would be used to further develop and refine its proprietary circulating tumor cell (CTC) identification and isolation technology.

"The funding we have obtained gives us a good runway to develop proof-of-concept that our diagnostic test has the sensitivity to detect cancer in a clinical setting," Liquid Biotech COO Jeffrey Janco said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.